表紙
市場調査レポート

世界の生物学的検出(バイオディテクション)市場

Global Bio-detection Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 322811
出版日 ページ情報 英文 63 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
世界の生物学的検出(バイオディテクション)市場 Global Bio-detection Market 2014-2018
出版日: 2015年01月07日 ページ情報: 英文 63 Pages
概要

生物学的検出システム(バイオディテクション・システム)は、病原体やウイルスなどの生物学的な刺激を電気信号に変換する分析装置です。生物学的検出市場は、2014年から2018年の間、14.19%のCAGRで拡大することが予測されています。この成長の主な要因のひとつは、バイオテロ攻撃の脅威が挙げられます。

当レポートでは、世界における生物学的検出(バイオディテクション)市場の現況と今後の見通しを調査しており、技術別および地域別の動向、市場の成長因子と課題、主要企業の分析などを提供しています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
    • 生物学的検出システムの製品ライフサイクル
  • 市場規模と予測
  • ファイブフォース分析

第7章 技術別の市場区分

  • 世界の技術世代別の生物学的検出市場
    • 第1世代
    • 第2世代
    • 第3世代

第8章 地理区分

  • 世界の地域別の生物学的検出市場
    • 南北アメリカの生物学的検出市場
    • 欧州・中東・アフリカ地域の生物学的検出市場
    • アジア太平洋地域の生物学的検出市場

第9章 市場の魅力

第10章 購入基準

第11章 市場成長因子

第12章 成長因子とその影響

第13章 市場の課題

第14章 成長因子と課題の影響

第15章 市場動向

第16章 動向とその影響

第17章 ベンダー情勢

  • 競合シナリオ
    • Agilent Technologies
    • Cepheid
    • Roche Diagnostics
    • Smiths Detection
  • その他の有力ベンダー

第18章 主要ベンダーの分析

  • Agilent Technologies
  • Cepheid
  • Roche Diagnostics
  • Smiths Detection

第19章 主な前提条件

第20章 関連レポート

目次
Product Code: IRTNTR4409

About Bio-detection

Bio-detection has emerged as a solution to the public and governments. With an increase in bio-terrorism, the occurrence of illness and deaths is very frequent. This event is caused by the airborne chemicals or pathogens that are released by a terrorist or a group of people or even by an individual for a motive. These pathogens can be detected by a system called bio-detection, which signals the entry or the existence of a virus. The increasing attacks have brought a major concern to the public as well as governments. Attacks such as the 2001 Anthrax scare, the 2003 severe acute respiratory syndrome (SARS), the 2004 Ricin letters, the 2009 H1N1, and the 2014 Ebola outbreaks have driven governments to increase their bio-surveillance budgets.

TechNavio's analysts forecast the Global Bio-detection market to grow at a CAGR of 14.19 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Bio-detection market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales, services, and upgrades of the bio-detection system in the Government sector.

The bio-detection systems considered in this report are listed below:

  • 1st generation bio-detection systems
  • 2nd generation bio-detection systems
  • 3rd generation bio-detection systems

TechNavio's report, the Global Bio-detection Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA region; it also covers the Global Bio-detection market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Agilent Technologies
  • Cepheid
  • Roche Diagnostics
  • Smiths Group

Other Prominent Vendors

  • 20/20 GeneSystems
  • 3M Microbiology
  • Advnt Biotechnologies
  • Alexeter Technologies
  • ANP Technologies
  • BAS - Biological Alarm Systems
  • BD Biosciences Immunocytometry Systems
  • Bertin Technologies
  • Biodefense
  • BioDETECT
  • BioSentinel Pharmaceuticals
  • BioTraces
  • BioVeris
  • Commonwealth Biotechnologies
  • Dycor Technologies
  • Environics
  • Evogen
  • General Dynamics Canada
  • GenPrime
  • Groton Biosystems
  • Haztech Systems
  • JMAR Technologies
  • New Horizons Diagnostics
  • Proengin
  • Response Biomedical
  • Tetracore

Market Driver

  • Need for Early Detection System for Bio-terrorist Attacks
  • For a full, detailed list, view our report

Market Challenge

  • Difficulties in Detecting Minute Presence of Pathogens
  • For a full, detailed list, view our report

Market Trend

  • Increased Need for Biosecurity
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview

Product Lifecycle of Bio-detection Systems

  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Technology

  • 07.1. Global Bio-detection Market by Technology Generation
  • 07.2. Global Bio-detection Market by Technology 2013-2018
    • 07.2.1. Global 1st Generation Bio-detection Market
    • 07.2.2. Global 2nd Generation Bio-detection Market
    • 07.2.3. Global 3rd Generation Bio-detection Market

08. Geographical Segmentation

  • 08.1. Global Bio-detection Market by Geographical Segmentation 2013
  • 08.2. Global Bio-detection Market by Geographical Segmentation 2013-2018
  • 08.3. Global Bio-detection Market by Geographical Segmentation 2013-2018
    • 08.3.1. Bio-Detection Market in the Americas
    • 08.3.2. Bio-Detection Market in the EMEA Region
    • 08.3.3. Bio-Detection Market in the APAC Region

09. Market Attractiveness

  • 09.1. Market Attractiveness by Geographical Segmentation

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Agilent Technologies
    • 17.1.2. Cepheid
    • 17.1.3. Roche Diagnostics
    • 17.1.4. Smiths Detection
  • 17.2. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Agilent Technologies
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Business Segmentation by Revenue 2013
    • 18.1.4. Business Segmentation by Revenue 2012 and 2013
    • 18.1.5. Geographical Segmentation by Revenue 2013
    • 18.1.6. Business Strategy
    • 18.1.7. Recent Developments
    • 18.1.8. SWOT Analysis
  • 18.2. Cepheid
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Business Segmentation
    • 18.2.4. Business Segmentation by Revenue 2012 and 2013
    • 18.2.5. Geographical Segmentation by Revenue 2013
    • 18.2.6. Business Strategy
    • 18.2.7. Recent Developments
    • 18.2.8. SWOT Analysis
  • 18.3. Roche Diagnostics
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation by Revenue 2013
    • 18.3.4. Geographical Segmentation by Revenue 2013
    • 18.3.5. Business Strategy
    • 18.3.6. Recent Developments
    • 18.3.7. SWOT Analysis
  • 18.4. Smiths Detection
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. Products and Solutions
    • 18.4.4. Service and Support
    • 18.4.5. Technologies
    • 18.4.6. Business Strategy
    • 18.4.7. Recent Developments
    • 18.4.8. SWOT Analysis

19. Key Assumptions

20. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Product Lifecycle of Bio-detection Systems
  • Exhibit 3: Global Bio-detection Market 2013-2018 (US$ billion)
  • Exhibit 4: Global Bio-detection Market by Technology Generation 2013-2018
  • Exhibit 5: Global Bio-detection Market by Technology 2013-2018 (US$ billion)
  • Exhibit 6: Global Bio-detection market by Geographical Segmentation 2013
  • Exhibit 7: Global Bio-detection Market by Geographical Segmentation 2013-2018 (percentage)
  • Exhibit 8: Global Bio-detection Market by Geographical Segmentation 2013-2018 (US$ billion)
  • Exhibit 9: Agilent Technologies: Business Segmentation by Revenue 2013
  • Exhibit 10: Agilent Technologies: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 11: Agilent Technologies: Geographical Segmentation by Revenue 2013
  • Exhibit 12: Cepheid: Business Segmentation 2013
  • Exhibit 13: Cepheid: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 14: Cepheid: Geographical Segmentation by Revenue 2013
  • Exhibit 15: Roche Diagnostics: Business Segmentation by Revenue 2013
  • Exhibit 16: Roche Diagnostics: Geographical Segmentation by Revenue 2013
  • Exhibit 17: Smiths Detection: Products and Solutions
  • Exhibit 18: Smiths Detection: Service and Support
  • Exhibit 19: Smiths Detection: Technologies
Back to Top